A novel ceramic material with medical application by Joanna Podporska et al.
19
Processing and Application of Ceramics  2 [1] (2008) 19–22
* Corresponding author: tel: +48 12 617 37 59,
fax: +48 12 633 15 93, e-mail: podpora@agh.edu.pl
A novel ceramic material with medical application
Joanna Podporska*, Marta Błażewicz, Barbara Trybalska, Łukasz Zych
Faculty of Materials Science and Ceramics, AGH - University of Science and Technology, Al. Mickiewicza 
30, 30-059 Krakow, Poland
Received 4 October 2007; received in revised form 7 April 2008; accepted 07 May 2008 
Abstract
Until now the basic methods used in manufacturing of wollastonite have been chemical (melting together 
with glass crystallization process, chemical coprecipitation) and sol – gel methods. A new and promising 
way of wollastonite fabrication is controlled pyrolysis of polysiloxane precursors with inorganic ﬁ  llers. 
Heat treatment of such mixtures leads to the formation of wollastonite-containing ceramics already at about 
1000°C. This is a relatively inexpensive and efﬁ  cient method which enables to obtain complex shapes of the 
samples.
The aim of this work was to obtain sintered, wollastonite-containing bioceramics and determine its bio-
active features. Samples were sintered at three different temperatures: 1000, 1100 and 1200°C. Then the 
bioactivity of the wollastonite-containing ceramics was investigated by the “in vitro” test in simulated 
body ﬂ  uid. On the basis of the achieved results, it can be assumed that the obtained material possesses 
bioactive features.
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I. Introduction
Wollastonite is a calcium metasilicate with the chem-
ical formula CaSiO3 [1]. It is commonly used in ceram-
ic and cement industry [2]. Furthermore wollastonite is 
characterized by speciﬁ  c bioactive features in contact 
with living tissue what makes it an attractive material in 
manufacturing of artiﬁ  cial bone and in bone tissue en-
gineering ﬁ  eld [2].
The characteristic feature of bioactive materials is 
the ability to form a hydroxyapatite (Hap) layer on their 
surface, after immersion in simulated body ﬂ  uid [3–6]. 
Moreover after comparing with bioglasses and apatite/
wollastonite glass-ceramics, it was found that the rate of 
Hap formation on CaSiO3 is faster [7].
Wollastonite-based ceramic can be manufactured by 
melting suitable raw materials followed by controlled 
crystallization of the glasses or by a sol-gel method 
[1,2]. The main drawbacks of the melting method are 
the multi-step preparation procedure and the relatively 
high processing temperatures (about 1500°C). The sol-
gel method offers lower processing temperatures (they 
do not exceed 1200°C), however it is expensive and has 
low efﬁ  ciency [1].
A novel and promising method of wollastonite man-
ufacturing containing ceramics is controlled pyrolysis 
of organosilicon precursors with adequate active ﬁ  ll-
ers. Heat treatment of such mixtures, depending on the 
type of polymer precursor, the type of active ﬁ  llers and 
the ﬁ  nal heat treatment temperature, leads to formation 
of wollastonite-containing ceramic material already at 
about 1000°C [1,2].
II. Materials and Methods
Lukosil 901 poly (methylphenylsiloxane) resin (Lu-
cebni Zavody, Kolin, Czech Republic), together with 
commercially available active ﬁ   llers (powders of 
Ca(OH)2 and nano-grain sized SiO2) were used. The 
resin was cured over the period of 7 days, in the tem-
perature ranging from 100°C to 150°C. The cured res-
in was ground together with active ﬁ  llers. Pellets were 
formed from the received powders and then heat-treat-
ed at 1000°C, in an inert atmosphere. The average heat-
ing rate was 0.7 °C/min and the total time of heat treat-20
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ment 24 hours. The obtained samples were ground in a 
vibrating mill (milling time was 2h and mill frequency 
12Hz) to a mean grain size of 0.5 μm. Pore size distribu-
tion was determined by the mercury poro  simetry meth-
od (Poremaster 60, Quantachrome Instr.).
In the next step, bars were formed by isostatic press-
ing (200 MPa) and sintering at the following tempera-
tures: 1000, 1100 and 1200°C (average heating rate was 
5 °C /min and holding time at max. temperature 2 h).
The materials were investigated by using FTIR 
(Fourier transform infrared) spectroscopy. FTIR absor-
bance spectra were collected with FTS-60 V Bio-Rad 
spectrometer. Spectra were collected over the 4000 to 
400 cm-1 wavenumber range, at a resolution of 4 cm-
1 and 256 scans were summed. A standard KBr pellet 
technique was used.
The structure of the obtained ceramic samples was 
examined with the use of the Philips X’Pert Pro MD 
powder diffractometer (Kα1 radiation from Cu anode, 
Ni ﬁ  ltered). Data analysis and the peak proﬁ  le ﬁ  tting 
procedure were carried out using Philips X’Pert High-
Score Plus (PW3212) Release 2.1 software. The pat-
terns were acquired in the 2Ө range from 3 to 90° at the 
room temperature.
In the bioactivity “in vitro” test, sintered samples 
were immersed in simulated body ﬂ  uid (SBF) solu-
tion. During the experiment time, the pH of SBF was 
controlled. The samples were immersed for 30 days at 
37°C. The simulated body ﬂ  uid solution was changed 
every 3–4 days to provide constant chemical composi-
tion of solution. Scanning electron microscopy (SEM) 
with EDS analysis (JEOL 5400 with LINK AN 10000 
point microanalyzer of X-ray radiation) was used to 
study morphology and chemical composition of the pre-
pared samples before and after the bioactivity test.
III. Results and Discussion
The FTIR spectrum (Fig. 1) of the sample obtained 
by controlled pyrolysis of polysiloxane resin with ad-
dition of active ﬁ  llers at 1000°C shows bands char-
acteristic for α-wollastonite [1]. The characteristic 
stretching vibrations of Si-O-Si bonds at 718 cm-1 can 
be observed. Furthermore, vibrations, associated with 
the bond mentioned above, are visible at 1072 and 
1095 cm-1. The bands at 923, 940 and 992 cm-1 cor-
responds to stretching vibrations of Si-O bond. Typi-
cal bending vibrations of -O-Si-O- bond can be seen at 
563 cm-1 [8-10]. 
XRD analysis (Fig. 2) conﬁ  rmed the presence of α-
CaSiO3. The mean grain size of crystallites measured 
according to the Scherrer equation is about 52 nm.
Fig. 3 shows cumulative pore size distribution 
curves in green samples made of wollastonite pow-
der produced by controlled pyrolysis. Pore size dis-
tribution in the sample made from the non-grounded 
powder was relatively wide, in the range of 0.5 to 2 
μm, indicating that the powder consisted of particles 
of various sizes. In contrary, pore size distribution in 
the sample made from the ground powder was narrow 
with modal pore diameter of about 0.5 μm. This sug-
gests that the grinding process was effective and pro-
duced particles of the similar size. Narrow pore size 
distribution in a green sample indicates homogenous 
particle arrangement, which is advantageous for its 
sintering process.
 The SEM micrographs of the pressed samples sin-
tered in 1000, 1100 and 1200°C are shown on the Fig. 
4. Signiﬁ  cant differences on surface morphology can be 
Figure 1. FTIR spectrum of wollastonite containing
ceramics after controlled pyrolysis in 1000°C
Figure 2. XRD pattern of wollastonite containing
ceramics obtained at 1000°C
Figure 3. Pore-size cumulative  curve of the powder before 
and after grinding process21
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Figure 4. SEM micrographs of samples obtained at: a) 1000°C, b) 1100°C and c) 1200°C
Figure 5. EDS point analysis of the samples sintered at: a) 1000°C, b) 1200°C, 
c) 1100°C (one position) and d) 1100°C (another position)
a) b)
c)22
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observed with the sintering temperature changes. The 
mean grain size of the material sintered at the 1000°C 
is about 0.6–1.2 μm. When the sintering temperature in-
creases, grain growth is visible and the morphology of 
material surface changes. The mean grain size for the 
samples sintered in 1100°C is about 2–5 μm and for 
the 1200°C, 4–10 μm. EDS analysis (Fig. 5) shows that 
during the sintering, changes in chemical composition 
of investigated materials can be observed. The samples 
sintered at 1000 and 1200°C contain wollastonite as the 
main phase. However, the samples sintered at 1100°C 
have an additional phase, consisting signiﬁ  cantly lower 
quantities of calcium. At temperature of 1100°C wollas-
tonite can be partly dissolved, creating another silicate 
(metastabile phase). EDS spectra of the sample sintered 
at 1100°C (Fig. 5c,d) conﬁ  rmed existing of peaks with 
different intensity of particular elements when analysis 
at different points was carried out.
Fig. 6 shows surface micrographs of the sample sur-
face after immersion in SBF for 30 days, together with 
EDS analysis. All the samples show very good bioac-
tivity. Surface is totally covered by the dense so-called 
cauliﬂ  ower shape crystalline layer characteristic for hy-
droxyapatite. The EDS analysis conﬁ  rms that this layer 
consists mostly of calcium and phosphorus atoms. The 
ratio Ca/P is similar to that in bone apatite. 
IV. Conclusions
The results show that thermal treatment of organo-
silicon precursors with active ﬁ  llers leads to obtaining 
ceramic material which contains nanocrystaline wollas-
tonite. Moreover sintering of such powders leads to ob-
taining of the samples with bioactive features, as indi-
cated by the results of the „in vitro” test in simulated 
body ﬂ  uid. 
On the basis of the achieved results it is assumed 
that the material obtained can be useful in the regenera-
tion of the bone tissue.
Figure 6. SEM micrograph (bar=20 μm) with EDS point analysis
of the samples after bioactivity test in SBF
Acknowledgements: This work is supported by the 
Ministry of Science and Higher Education in Poland. 
Grant no: 18.18.160.379
References
1. C. Paluszkiewicz, T. Gumuła, J. Podporska, M. 
Błażewicz, “Structure and bioactivity studies of new 
polysiloxane-derived materials for orthopedic applica-
tions”, J. Mol. Struct., 792-793 (2006) 176–181
2. T. Gumuła, J. Podporska, M. Błażewicz, “Biocer-
amics obtained from polymer precursors as a bone 
tissue substitute”, Inżynieria Biomateriałów, 47-53 
(2005) 85–87.
3.  P.N. De Aza, J. M. Fernandez-Pradas, P. Serra, “In 
vitro bioactivity of laser ablation pseudo  wollastonite 
coating”, Biomaterials, 25 [11] (2004) 1983–1990.
4.  T. Kokubo, “Design of bioactive bone substitutes based 
on biomineralization process”, Mater. Sci. Eng., C25 
(2005) 97–104.
5.  P.N. De Aza, F. Guitian, S. De Aza, “A new bioactive 
material which transforms in situ into hydroxyapatite”, 
Acta Mater., 46 [7] (1998) 2541–2549.
6.  M. Szumera, I. Wacławska, W. Mozgawa, M. Sitarz, 
“Spectroscopic study of biologically active glasses”,   
J. Mol. Struct., 744-747 (2005) 609–614.
7.  X. Wan, C. Chang, D. Mao, L. Jiang, M. Li, “Prepara-
tion and in vitro bioactivities of calcium silicate nan-
ophase materials”, Mater. Sci. Eng., C25 (2005) 455–
461.
8.  M. Handke, M. Sitarz, W. Mozgawa, “Model of sili-
cooxygen ring vibration”, J. Mol. Struct., 450 (1998) 
229–238.
9.  M. Sitarz, W. Mozgawa, M. Handke, “Vibrational spec-
tra of complex ring silicate anions – method of recog-
nition”, J. Mol. Struct., 404 (1997) 193–197
10. M. Sitarz, M. Handke, W. Mozgawa, “FTIR studies of 
the cyclosilicate-like structures”, J. Mol. Struct., 596 
(2001) 185–189.